Literature DB >> 19625266

Risk factors for nonfatal pulmonary embolism in a Japanese population: A hospital-based case-control study.

Norikazu Yamada1, Satoshi Ota, Ying Liu, Martin M Crane, Cindy M Chang, Samruddhi Thaker, Mashio Nakamura, Masaaki Ito.   

Abstract

Risk factors for pulmonary embolism (PE) have been identified among populations in Western countries but have not been well characterized in Japan. A hospital-based case-control design employed cases with PE, which diagnosed by standard imaging techniques; controls were individuals drawn by systematic random sampling from the hospital admission register. A total of 100 (38 males and 62 females) and 199 controls were identified. Patients with PE were younger (56.5 vs 60.9 years) and more likely to be female. The odds ratio ([OR] adjusted for other factors) and 95% confidence interval (CI) for risk of PE was elevated for the following: female gender, prolonged immobilization, history of prior venous thromboembolism (VTE), lower extremity varicose veins, body mass index (BMI) > or = 25 kg/m( 2), extremity paralysis, and gout/hyperuricemia. Inherited thrombophilia was found in 14 patients with PE (14%). Risk factors for PE in Japan are comparable in magnitude to those in Western countries; only one third of PE cases had received VTE prophylaxis.

Entities:  

Mesh:

Year:  2009        PMID: 19625266     DOI: 10.1177/0003319709335907

Source DB:  PubMed          Journal:  Angiology        ISSN: 0003-3197            Impact factor:   3.619


  8 in total

1.  Invited commentary: Diet and risk of venous thromboembolism--a hard nut to crack.

Authors:  Pamela L Lutsey
Journal:  Am J Epidemiol       Date:  2011-12-15       Impact factor: 4.897

2.  Venous thromboembolism in patients with gout and the impact of hospital admission, disease duration and urate-lowering therapy.

Authors:  Alyshah Abdul Sultan; Sara Muller; Rebecca Whittle; Edward Roddy; Christian Mallen; Lorna Clarson
Journal:  CMAJ       Date:  2019-06-03       Impact factor: 8.262

3.  Changes in the incidence, case fatality rate, and characteristics of symptomatic perioperative pulmonary thromboembolism in Japan: Results of the 2002-2011 Japanese Society of Anesthesiologists Perioperative Pulmonary Thromboembolism (JSA-PTE) Study.

Authors:  Masayuki Kuroiwa; Hiroshi Morimatsu; Koichi Tsuzaki; Kazuo Irita; Michiyoshi Sanuki; Hideki Nakatsuka; Mashio Nakamura
Journal:  J Anesth       Date:  2014-11-21       Impact factor: 2.078

4.  Association between previous history of gout attack and risk of deep vein thrombosis - a nationwide population-based cohort study.

Authors:  Chun-Chih Chiu; Yung-Tai Chen; Chien-Yi Hsu; Chun-Chin Chang; Chin-Chou Huang; Hsin-Bang Leu; Szu-Yuan Li; Shu-Chen Kuo; Po-Hsun Huang; Jaw-Wen Chen; Shing-Jong Lin
Journal:  Sci Rep       Date:  2016-05-27       Impact factor: 4.379

5.  Construction of ultrasound-responsive urokinase precise controlled-release nanoliposome applied for thrombolysis.

Authors:  Yongliang Fan; Li Liu; Fang Li; Hang Zhou; Yizhou Ye; Chunping Yuan; Hongli Shan; Wangfu Zang; Yu Luo; Sijing Yan
Journal:  Front Bioeng Biotechnol       Date:  2022-08-09

Review 6.  Current and former smoking and risk for venous thromboembolism: a systematic review and meta-analysis.

Authors:  Yun-Jiu Cheng; Zhi-Hao Liu; Feng-Juan Yao; Wu-Tao Zeng; Dong-Dan Zheng; Yu-Gang Dong; Su-Hua Wu
Journal:  PLoS Med       Date:  2013-09-17       Impact factor: 11.069

7.  Prognostic value of blood biomarkers in patients with unprovoked acute pulmonary embolism.

Authors:  Joo Hee Lee; Jin Won Huh; Sang-Bum Hong; Yeon-Mok Oh; Tae Sun Shim; Chae-Man Lim; Sang-Do Lee; Younsuck Koh; Woo Sung Kim; Jae Seung Lee
Journal:  Ann Thorac Med       Date:  2019 Oct-Dec       Impact factor: 2.219

8.  An Independent Risk of Gout on the Development of Deep Vein Thrombosis and Pulmonary Embolism: A Nationwide, Population-Based Cohort Study.

Authors:  Chien-Chung Huang; Po-Hao Huang; Jiunn-Horng Chen; Joung-Liang Lan; Gregory J Tsay; Hsiao-Yi Lin; Chun-Hung Tseng; Cheng-Li Lin; Chung-Yi Hsu
Journal:  Medicine (Baltimore)       Date:  2015-12       Impact factor: 1.817

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.